Page 348 - Read Online

Liu et al. Novel predictive and prognostic strategies of HBV-related HCC

hepatocellular carcinoma. Cancer Lett 2014;343:161-71. 48. Andrisani OM, Studach L, Merle P. Gene signatures in hepatocellular
33. Liu S, Xie J, Yin J, Zhang H, Zhang Q, Pu R, Li C, Ni W, Wang H, carcinoma (HCC). Semin Cancer Biol 2011;21:4-9.
Cao G. A matched case-control study of hepatitis B virus mutations 49. Lee JS, Heo J, Libbrecht L, Chu IS, Kaposi-Novak P, Calvisi
in the preS and core promoter regions associated independently with DF, Mikaelyan A, Roberts LR, Demetris AJ, Sun Z, Nevens F,
hepatocellular carcinoma. J Med Virol 2011;83:45-53. Roskams T, Thorgeirsson SS. A novel prognostic subtype of human
34. Xie JX, Zhao J, Yin JH, Zhang Q, Pu R, Lu WY, Zhang HW, Wang hepatocellular carcinoma derived from hepatic progenitor cells. Nat
HY, Cao GW. Association of novel mutations and haplotypes in the Med 2006;12:410-6.
preS region of hepatitis B virus with hepatocellular carcinoma. Front 50. Budhu A, Forgues M, Ye QH, Jia HL, He P, Zanetti KA, Kammula
Med China 2010;4:419-29. US, Chen Y, Qin LX, Tang ZY, Wang XW. Prediction of venous
35. Yuen MF, Tanaka Y, Fong D Y, Fung J, Wong D K, Yuen J C, But metastases, recurrence, and prognosis in hepatocellular carcinoma
D Y, Chan A O, Wong B C, Mizokami M, Lai C L. Independent risk based on a unique immune response signature of the liver
factors and predictive score for the development of hepatocellular microenvironment. Cancer Cell 2006;10:99-111.
carcinoma in chronic hepatitis B. J Hepatol 2009;50:80-8. 51. Kaposi-Novak P, Lee JS, Gomez-Quiroz L, Coulouarn C, Factor
36. Yin J, Wang J, Pu R, Xin H, Li Z, Han X, Ding Y, Du Y, Liu W, VM, Thorgeirsson SS. Met-regulated expression signature defines a
Deng Y, Ji X, Wu M, Yu M, Zhang H, Wang H, Thompson TC, Ni W, subset of human hepatocellular carcinomas with poor prognosis and
Cao G. Hepatitis B virus combo mutations improve the prediction and aggressive phenotype. J Clin Invest 2006;116:1582-95.
active prophylaxis of hepatocellular carcinoma: a clinic-based cohort 52. Wang SM, Ooi LL, Hui KM. Identification and validation of a novel
study. Cancer Prev Res (Phila) 2015;8:978-88. gene signature associated with the recurrence of human hepatocellular
37. Han YF, Zhao J, Ma LY, Yin JH, Chang WJ, Zhang HW, Cao carcinoma. Clin Cancer Res 2007;13:6275-83.
GW. Factors predicting occurrence and prognosis of hepatitis-B- 53. Boyault S, Rickman DS, de Reynies A, Balabaud C, Rebouissou S,
virus-related hepatocellular carcinoma. World J Gastroenterol Jeannot E, Herault A, Saric J, Belghiti J, Franco D, Bioulac-Sage
2011;17:4258-70. P, Laurent-Puig P, Zucman-Rossi J. Transcriptome classification of
38. Chew V, Tow C, Teo M, Wong HL, Chan J, Gehring A, Loh M, HCC is related to gene alterations and to new therapeutic targets.
Bolze A, Quek R, Lee VK, Lee KH, Abastado JP, Toh HC, Nardin A. Hepatology 2007;45:42-52.
Inflammatory tumour microenvironment is associated with superior 54. Woo HG, Park ES, Cheon JH, Kim JH, Lee JS, Park BJ, Kim W, Park
survival in hepatocellular carcinoma patients. J Hepatol 2010;52:370- SC, Chung YJ, Kim BG, Yoon JH, Lee HS, Kim CY, Yi NJ, Suh
9. KS, Lee KU, Chu IS, Roskams T, Thorgeirsson SS, Kim YJ. Gene
39. Gao Q, Qiu SJ, Fan J, Zhou J, Wang XY, Xiao YS, Xu Y, Li YW, expression-based recurrence prediction of hepatitis B virus-related
Tang ZY. Intratumoral balance of regulatory and cytotoxic T cells is human hepatocellular carcinoma. Clin Cancer Res 2008;14:2056-64.
associated with prognosis of hepatocellular carcinoma after resection. 55. Hoshida Y, Villanueva A, Kobayashi M, Peix J, Chiang DY,
J Clin Oncol 2007;25:2586-93. Camargo A, Gupta S, Moore J, Wrobel MJ, Lerner J, Reich M, Chan
40. Du Q, Zhang X, Cardinal J, Cao Z, Guo Z, Shao L, Geller DA. Wnt/ JA, Glickman JN, Ikeda K, Hashimoto M, Watanabe G, Daidone
beta-catenin signaling regulates cytokine-induced human inducible MG, Roayaie S, Schwartz M, Thung S, Salvesen HB, Gabriel S,
nitric oxide synthase expression by inhibiting nuclear factor-kappaB Mazzaferro V, Bruix J, Friedman SL, Kumada H, Llovet JM, Golub
activation in cancer cells. Cancer Res 2009;69:3764-71. TR. Gene expression in fixed tissues and outcome in hepatocellular
41. Pan L, Yao M, Zheng W, Gu J, Yang X, Qiu L, Cai Y, Wu W, Yao carcinoma. N Engl J Med 2008;359:1995-2004.
D. Abnormality of Wnt3a expression as novel specific biomarker for 56. Coulouarn C, Factor VM, Thorgeirsson SS. Transforming growth
diagnosis and differentiation of hepatocellular carcinoma. Tumour factor-beta gene expression signature in mouse hepatocytes predicts
Biol 2016;37:5561-8. clinical outcome in human cancer. Hepatology 2008;47:2059-67.
42. Ding SL, Yang ZW, Wang J, Zhang XL, Chen XM, Lu FM. 57. Yoshioka S, Takemasa I, Nagano H, Kittaka N, Noda T, Wada
Integrative analysis of aberrant Wnt signaling in hepatitis B H, Kobayashi S, Marubashi S, Takeda Y, Umeshita K, Dono K,
virus-related hepatocellular carcinoma. World J Gastroenterol Matsubara K, Monden M. Molecular prediction of early recurrence
2015;21:6317-28. after resection of hepatocellular carcinoma. Eur J Cancer
43. Fabregat I. Dysregulation of apoptosis in hepatocellular carcinoma 2009;45:881-9.
cells. World J Gastroenterol 2009;15: 513-20. 58. Woo HG, Lee JH, Yoon JH, Kim CY, Lee HS, Jang JJ, Yi NJ, Suh
44. He Y, Zhang H, Yin J, Xie J, Tan X, Liu S, Zhang Q, Li C, Zhao KS, Lee KU, Park ES, Thorgeirsson S S, Kim Y J. Identification of
J, Wang H, Cao G. IkappaBalpha gene promoter polymorphisms a cholangiocarcinoma-like gene expression trait in hepatocellular
are associated with hepatocarcinogenesis in patients infected with carcinoma. Cancer Res 2010;70:3034-41.
hepatitis B virus genotype C. Carcinogenesis 2009;30:1916-22. 59. Roessler S, Jia HL, Budhu A, Forgues M, Ye QH, Lee JS,
45. Du Y, Han X, Pu R, Xie J, Zhang Y, Cao G. Association of miRNA- Thorgeirsson SS, Sun Z, Tang ZY, Qin LX, Wang XW. A unique
122-binding site polymorphism at the interleukin-1 alpha gene and metastasis gene signature enables prediction of tumor relapse in early-
its interaction with hepatitis B virus mutations with hepatocellular stage hepatocellular carcinoma patients. Cancer Res 2010;70:10202-
carcinoma risk. Front Med 2014;8:217-26. 12.
46. Han Y, Pu R, Han X, Zhao J, Li W, Yin J, Zhang Y, Shen Q, Xie J, 60. Villanueva A, Hoshida Y, Battiston C, Tovar V, Sia D, Alsinet C,
Zhang Q, Jiang S, Li J, Zhang H, Wang H, Cao G. Association of a Cornella H, Liberzon A, Kobayashi M, Kumada H, Thung S N, Bruix
potential functional pre-miR-218 polymorphism and its interaction J, Newell P, April C, Fan JB, Roayaie S, Mazzaferro V, Schwartz ME,
with hepatitis B virus mutations with hepatocellular carcinoma risk. Llovet JM. Combining clinical, pathology, and gene expression data
Liver Int 2014;34:728-36. to predict recurrence of hepatocellular carcinoma. Gastroenterology
47. Ji X, Zhang Q, Li B, Du Y, Yin J, Liu W, Zhang H, Cao G. Impacts 2011;140:1501-12.
of human leukocyte antigen DQ genetic polymorphisms and their 61. Minguez B, Hoshida Y, Villanueva A, Toffanin S, Cabellos L, Thung
interactions with hepatitis B virus mutations on the risks of viral S, Mandeli J, Sia D, April C, Fan J B, Lachenmayer A, Savic R,
persistence, liver cirrhosis, and hepatocellular carcinoma. Infect Genet Roayaie S, Mazzaferro V, Bruix J, Schwartz M, Friedman S L, Llovet
Evol 2014;28:201-9. JM. Gene-expression signature of vascular invasion in hepatocellular
Hepatoma Research ¦ Volume 2 ¦ December 23, 2016 339